Literature DB >> 27870798

RETINAL ANGIOMATOUS PROLIFERATION DIAGNOSIS: A Multiimaging Approach.

Vittoria Ravera1, Ferdinando Bottoni, Andrea Giani, Mario Cigada, Giovanni Staurenghi.   

Abstract

PURPOSE: To identify signs occurring more frequently in retinal angiomatous proliferation (RAP) lesions compared with other types of choroidal neovascularization (CNV) in age-related macular degeneration.
METHODS: In this cross-sectional retrospective study, 30 patients were evaluated. These signs were correlated with the type of CNV: shunting of blood flow to the lesion by fluorescein angiography, late leakage by indocyanine green angiography, intraretinal cysts and retinal pigmented epithelium interruption along the retinal pigmented epithelium detachment with a hyperreflective oval area by spectral domain optical coherence tomography, and presence of reticular pseudodrusen by infrared light.
RESULTS: Shunting of blood flow was found in 56% of RAP, whereas it was absent in 100% of other CNVs. Late leakage in indocyanine green angiography occurred in all RAP cases, while it was found in 7% of other CNVs. Intraretinal cysts were detected in 100% of RAP cases and in 14% of other CNVs. Retinal pigmented epithelium interruption along the retinal pigmented epithelium detachment was evident in 93% of RAP cases and in 15% of other CNVs. Reticular pseudodrusen were present in 87% of RAP cases and in 21% of other CNVs.
CONCLUSION: All the signs investigated were strongly associated to RAP lesions. A multimodal imaging approach may help differentiating subtypes of neovascularization.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27870798     DOI: 10.1097/IAE.0000000000001152

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  8 in total

1.  Age-Related Macular Degeneration: Epidemiology and Clinical Aspects.

Authors:  Tiarnán D L Keenan; Catherine A Cukras; Emily Y Chew
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Intraretinal Cysts as a Manifestation of Retinal Angiomatous Proliferation in Optical Coherence Tomography Angiography.

Authors:  Jakub J Kałużny; Przemysław Zabel; Beata Danek; Damian Jaworski; Jarosław Makowski
Journal:  Medicina (Kaunas)       Date:  2022-05-19       Impact factor: 2.948

3.  The RAP study, report 3: Discoloration of the macular region in patients with macular neovascularization type 3.

Authors:  Bilal Haj Najeeb; Gabor G Deak; Ursula Schmidt-Erfurth; Bianca S Gerendas
Journal:  Acta Ophthalmol       Date:  2021-04-05       Impact factor: 3.988

4.  Short-term efficacy of intravitreal Aflibercept injections for retinal angiomatous proliferation.

Authors:  Hung-Da Chou; Wei-Chi Wu; Nan-Kai Wang; Lan-Hsin Chuang; Kuan-Jen Chen; Chi-Chun Lai
Journal:  BMC Ophthalmol       Date:  2017-06-27       Impact factor: 2.209

Review 5.  Spotlight on reticular pseudodrusen.

Authors:  Alessandro Rabiolo; Riccardo Sacconi; Maria Vittoria Cicinelli; Lea Querques; Francesco Bandello; Giuseppe Querques
Journal:  Clin Ophthalmol       Date:  2017-09-20

6.  Intra- and Intergrader Agreement for Detection of OCT Angiographic Characteristics Associated With Type 3 Neovascularization.

Authors:  Lisette M Smid; Mirjam E J van Velthoven; King T Wong; José P Martinez-Ciriano; Koenraad A Vermeer
Journal:  Transl Vis Sci Technol       Date:  2021-01-08       Impact factor: 3.283

7.  The RAP study, report 4: morphological and topographical characteristics of multifocal macular neovascularization type 3.

Authors:  Bilal Haj Najeeb; Gabor G Deak; Stefan Sacu; Ursula Schmidt-Erfurth; Bianca S Gerendas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-08-26       Impact factor: 3.117

8.  Long-Term Outcome of Eyes with Vitrectomy for Submacular and/or Vitreous Hemorrhage in Neovascular Age-Related Macular Degeneration.

Authors:  Setsuko Kawakami; Yoshihiro Wakabayashi; Kazuhiko Umazume; Yoshihiko Usui; Daisuke Muramatsu; Tsuyoshi Agawa; Kaori Yamamoto; Hiroshi Goto
Journal:  J Ophthalmol       Date:  2021-11-02       Impact factor: 1.909

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.